Medis Pharma Lithuania - Company finances
|
EUR
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 182,244 | 294,568 | 657,529 | 970,032 | 920,820 | 1,309,030 |
| Profit before tax | - | - | - | - | - | - |
| Net profit | 4,319 | 6,913 | 14,338 | 18,673 | 20,121 | 38,651 |
| Equity | 6,819 | 13,732 | 28,070 | 46,743 | 66,864 | 105,516 |
| Liabilities | 42,246 | 31,147 | 45,423 | 81,589 | 66,384 | 57,102 |
| Non-current assets | 3,126 | 3,459 | 8,490 | 8,499 | 11,149 | 9,992 |
| Current assets | 46,374 | 43,503 | 80,460 | 124,279 | 133,009 | 169,264 |
| Total assets | 49,500 | 46,962 | 88,950 | 132,778 | 144,158 | 179,256 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 51,088 | 63,404 | 71,648 |
| Social insurance contributions | - | - | - | 98,290 | 95,116 | 119,152 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +61.6% | +123.2% | +47.5% | -5.1% | +42.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.7% | 14.7% | 16.1% | 14.1% | 14.0% | 21.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 63.3% | 50.3% | 51.1% | 39.9% | 30.1% | 36.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.4% | 2.3% | 2.2% | 1.9% | 2.2% | 3.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 6.2 | 2.3 | 1.6 | 1.7 | 1.0 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 95,082 | 126,245 | 121,389 | 129,338 | 116,314 | 148,193 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medis Pharma Lithuania - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-17 | 569.35 |
| 2026-01-18 | 2026-01-18 | 309.47 |
| 2025-12-16 | 2025-12-16 | 590.85 |
| 2025-11-18 | 2025-12-04 | 55.84 |
| 2025-10-23 | 2025-11-04 | 0.31 |
| 2025-10-17 | 2025-10-19 | 125.78 |
| 2025-09-16 | 2025-09-25 | 7.77 |
| 2025-08-31 | 2025-09-03 | 7.77 |
| 2025-08-19 | 2025-08-29 | 7.77 |
| 2025-07-28 | 2025-08-04 | 7.77 |
| 2025-07-26 | 2025-07-27 | 7.07 |
| 2025-07-24 | 2025-07-25 | 7.77 |
| 2025-07-16 | 2025-07-23 | 7.07 |
| 2025-06-24 | 2025-07-03 | 7.07 |
| 2025-06-19 | 2025-06-23 | 195.99 |
| 2025-06-17 | 2025-06-18 | 7.08 |
| 2025-05-20 | 2025-05-27 | 50.95 |
| 2025-04-30 | 2025-04-30 | 0.52 |
| 2025-04-23 | 2025-04-27 | 145.65 |
| 2025-04-16 | 2025-04-22 | 0.52 |
| 2025-03-18 | 2025-04-03 | 0.52 |
| 2025-02-18 | 2025-03-04 | 0.52 |
| 2025-02-10 | 2025-02-10 | 0.52 |
| 2025-01-22 | 2025-02-04 | 0.52 |
| 2024-11-21 | 2024-12-01 | 2.06 |
| 2024-11-19 | 2024-11-20 | 214.45 |
| 2024-11-18 | 2024-11-18 | 2.06 |
| 2024-10-16 | 2024-11-05 | 2.06 |
| 2024-02-29 | 2024-03-04 | 82.01 |
| 2023-03-22 | 2023-03-29 | 21.23 |
| 2022-12-16 | 2023-01-04 | 0.22 |
| 2022-11-21 | 2022-12-04 | 0.22 |
| 2022-11-17 | 2022-11-18 | 0.22 |
| 2022-10-28 | 2022-11-03 | 0.22 |
| 2022-09-29 | 2022-10-02 | 72.45 |
| 2022-09-16 | 2022-09-28 | 4.72 |
| 2022-08-23 | 2022-09-04 | 4.72 |
| 2022-08-03 | 2022-08-04 | 70.77 |
| 2022-07-25 | 2022-08-02 | 4.72 |
| 2022-07-18 | 2022-07-24 | 3.05 |
| 2022-06-16 | 2022-07-04 | 3.05 |
| 2022-05-31 | 2022-06-05 | 216.12 |
| 2022-05-27 | 2022-05-30 | 97.38 |
| 2022-05-26 | 2022-05-26 | 3.05 |
| 2022-02-21 | 2022-02-24 | 1.22 |
Medis Pharma Lithuania - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medis Pharma Lithuania, UAB (code 305405895) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, the company generated revenue of €1.31 million and net profit of €38.7 thousand, with a profit margin of 3.0%. Revenue increased by 42.2% year on year and by 35.0% over two years, showing a clear upward trend after €970.0 thousand in 2023 and €920.8 thousand in 2024. Net profit also improved from €18.7 thousand in 2023 to €20.1 thousand in 2024 and €38.7 thousand in 2025. At the end of 2025, total assets amounted to €179.3 thousand, equity to €105.5 thousand and liabilities to €57.1 thousand. The equity ratio stood at 58.9% and debt-to-equity at 0.54, indicating a relatively conservative balance sheet structure. Asset turnover was 7.30x, ROE was 36.6% and ROA was 21.6%. With revenue per employee of €163.6 thousand and profit per employee of €4.8 thousand, the business showed solid operating efficiency in 2025.